Lockheed Martin Corporation (LMT)

Lockheed Martin shares closed at $609.92 after a run of strong analyst activity, with the stock trading above its 50-day and 200-day moving averages ($550.83 and $569.10) and the CleaRank rating at Buy. The most recent flow of news is analyst-driven: Morgan Stanley upgraded the stock to Overweight on October 26, 2026, and Guggenheim started coverage at Buy on November 4, 2026. The stock is 11.86% below its 52-week high of $692.00, so the question for holders is whether the recent gains can hold as the price approaches that peak. The stock's valuation is the main reason it scores well. At a trailing P/E of 21.66 it trades at a discount to the sector median of 34.0, and it sells at 1.78 times sales against a sector median of 4.0.

Analyst sentiment has firmed in recent weeks. Morgan Stanley upgraded the stock to Overweight from Equal-Weight on October 26, 2026, and Guggenheim started coverage at Buy on November 4, 2026. Citigroup and UBS both kept Buy ratings on October 23, 2026, while Wells Fargo kept its Equal-Weight rating on November 2, 2026, and JP Morgan kept its Neutral rating on October 26, 2026. Of 24 analysts with a current rating, 12 rate the stock buy or strong buy, 11 hold it and one sells, against seven buy ratings out of 21 three months ago.

The stock has beaten EPS estimates in five of its last seven reports. The October 22, 2026 report delivered adjusted EPS of $7.97 against an estimate of $7.52, a beat of 5.98%, and the share price rose 6.96% in the first session after it. The July 23, 2026 report beat by 10.43%, and the stock rose 10.54% the next session. The record is not one-directional. Of the seven reports, the two misses were not followed by a higher price in every case, and in three of the seven reports the price fell in the first session. The October 21, 2025 beat of 9.28% was followed by a 3.24% decline, so a beat has not always translated into a gain on the day.

At a trailing P/E of 21.66, the stock trades at a discount to the sector median P/E of 34.0, which is 36.3% below it. Its price-to-sales ratio of 1.78 compares with a sector median of 4.0. Return on equity of 80.19% is well above the sector median of 17.8%, though debt-to-equity of 2.04 is a reminder that the high return is partly built on borrowing.

The stock is 10.73% above its 50-day SMA and 7.17% above its 200-day SMA, and it rose 19.15% over the past month. Its beta against the S&P 500 is 0.08, and its typical daily move is 2.64%, so it has moved largely on its own news rather than with the broad market. The RSI of 58.2 is in the neutral zone, with the MACD line positive.

The base case is that the stock keeps trading in a range set by its moving averages, with earnings and analyst ratings as the main drivers. The price sits 3.33% above the 20-day EMA and 10.73% above the 50-day SMA, so a pause near $590.30 would be consistent with an uptrend that is still intact. Analysts' median 12-month price target is $661.50, 8.5% above the price, while the lowest target is $498.00 and the highest is $835.00. Analysts expect EPS to grow 42.5% this fiscal year and 8.8% next year, so the outlook rests on those estimates being delivered. The case would improve if the stock closes above the 52-week high of $692.00 and if the next earnings report matches the beat pattern of the last few quarters. Insider sales of $16.2M over the last 18 months, with no open-market purchases, are a weaker signal but worth watching.

Support sits at $590.30, the 20-day EMA, which is the nearest level below the price. Below it is the 200-day SMA at $569.10, then the 50-day SMA at $550.83. The 52-week low of $437.25 is the deepest support level. Resistance sits at the 52-week high of $692.00, the only level above the price. A close above it would mark a new high for the stock over the past year.